Testing medication for opioid use disorder in justice settings
This trial studies how to best increase the use of medication for opioid use disorder (MOUD) in jails or prisons. Sites that join will test ways to start or expand access to these life-saving treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your facility must want to use or expand medications for opioid use disorder.
- Your facility must have money set aside to pay for medication for 24 months.
- Your facility must agree to use at least one medication for opioid withdrawal or treatment.
- Leaders at all levels (like the prison director and medical staff) must support this.
- Your facility must sign a partnership agreement and share data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for staff in jails and prisons who want to expand access to methadone, a medication that helps people with opioid addiction. By participating, you can help shape how methadone is offered in correctional facilities, which could improve health outcomes for inmates.
This trial tests a counseling approach called “contingency management,” which uses structured incentives to reduce stimulant use. It’s meant for people receiving treatment in specialty addiction programs and/or newly starting opioid-use medication who also use stimulants.
This study tests a system to improve care for people with opioid use disorder as they leave jail and return to the community. It aims to help patients stay in treatment and avoid interruptions.
This study tests a program that offers support and incentives to help people continue their medication for opioid use disorder after leaving jail. It aims to improve treatment engagement and reduce relapse.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This trial tests a reward-based program (contingency management) to help inpatients with opioid use disorder stay in treatment and avoid drug use. It may help by providing incentives for attending sessions and testing clean.
Hear when a new Incarcerated Individuals trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.